ABSTRACT DDT, MF-2 cells, which are derived from hamster vas deferens smooth muscle, contain a1-adrenergic receptors (54,800 ± 2700 sites per cell) that are coupled to stimulation of inositol phospholipid metabolism. Incubation of these cells with tumor-promoting phorbol esters, which stimulate calcium-and phospholipid-dependent protein kinase, leads to a marked attenuation of the ability of a,-receptor agonists such as norepinephrine to stimulate the turnover of inositol phospholipids. This turnover was measured by determining the 32p content of phosphatidylinositol and phosphatidic acid after prelabeling of the cellular ATP pool with 32p;. These phorbol ester-treated cells also displayed a decrease in binding affinity of cellular al receptors for agonists with no change in antagonist affinity. By using affinity chromatography on the affinity resin Affi-Gel-A55414, the a, receptors were purified =300-fold from control and phorbol ester-treated 32P1-prelabeled cells. As assessed by NaDodSO4/polyacrylamide gel electrophoresis, the Mr 80,000 a,-receptor ligandbinding subunit is a phosphopeptide containing 1.2 mol of phosphate per mol of a, receptor. After phorbol ester treatment this increased to 3.6 mol of phosphate per mol of a, receptor. The effect of phorbol esters on norepinephrinestimulated inositol phospholipid turnover and a,-receptor phosphorylation showed the same rapid time course with a til2 < 2 min. These results indicate that calcium-and phospholipid-dependent protein kinase may play an important role in regulating the function of receptors that are coupled to the inositol phospholipid cycle by phosphorylating and deactivating them.
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The mechanisms whereby hormones regulate cellular metabolism are of great current biochemical interest. In addition to the well-delineated, second messenger-generating adenylate cyclase system, another potentially quite general pathway has been demonstrated recently. This pathway involves receptor-mediated stimulation of the breakdown of membrane polyphosphoinositides (phosphatidylinositol phosphates) to diacylglycerol and inositol trisphosphate (1) (2) (3) (4) (5) .
Both products are potential second messengers serving to stimulate calcium-and phospholipid-dependent protein kinase (protein kinase C) (6, 7) and to mobilize intracellular calcium (8, 9) , respectively. Factors known to stimulate this pathway include agonists such as acetylcholine (10) , angiotensin (11) , and catecholamines acting via a1-adrenergic receptors (1, (12) (13) (14) (15) (16) .
A powerful approach to the study of this signal transfer pathway has been the use of the tumor-promoting phorbol esters, which appear to mimic endogenously produced diacylglycerol in activating protein kinase C (17, 18) , thus bypassing the receptor signal. By using this approach it has been demonstrated recently that receptors for epidermal growth factor (19, 20) , insulin (21, 22) , and somatomedin C (21) are either directly or indirectly phosphorylated by protein kinase C. Although in a few of these systems receptor phosphorylation has been shown to correlate with alterations in ligand binding (23) (24) (25) (26) , almost nothing is known about the possible relationship of these phosphorylation events to alterations in physiological responsiveness. Moreover, the biochemical signal transfer pathways for these receptors have not yet been clearly elucidated. The adenylate cyclasecoupled ,3-adrenergic receptors have also been shown to be a target of protein kinase C-mediated phosphorylation (27, 28) . This covalent modification of the f3 receptor appears to uncouple it from adenylate cyclase stimulation, thus leading to "desensitization" of the receptor response.
Protein kinase C is presumably activated subsequent to the stimulation of receptors that lead to the breakdown of polyphosphoinositides. Thus, agonist-promoted protein kinase C-mediated phosphorylation of such receptors might serve as a mechanism for feedback regulation of the functions of those receptors. In the present studies we sought to test whether the activation of protein kinase C by phorbol esters leads to alterations of a1-adrenergic receptor function. Our results indicate a striking phorbol ester-induced uncoupling of a1-receptor-mediated stimulation of phosphatidylinositol (PtdIns) turnover paralleled by phosphorylation of the a,-adrenergic receptor protein in cultured DDT1 MF-2 smooth muscle cells.
MATERIALS AND METHODS A55414 {4-amino-6,7-dimethoxy-2[4'-(4"-aminobenzyl)1-piperazinyliquinazoline; see also Fig. 3} , a prazosin analogue and a potent a1-adrenergic antagonist, was prepared at Abbott Laboratories, and its synthesis and biological activity will be described separately.
Cell Growth and Labeling. DDT1 MF-2 cells were grown in 3-liter suspension cultures as described by Cornett and Norris (30) . Cells (109) were then incubated in phosphate-free Dulbecco's modified Eagle's medium (DMEM) with 6 mCi (1 Ci = 37 GBq) of 32P, in a total volume of 60 ml for 1 hr at 37°C. 
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of ice-cold buffer (50 mM Tris HCl/10 mM NaF, pH 7.4) and centrifugation. The cells were washed once in the same buffer.
Labeling of Phospholipids. Cells were washed with phosphate-free DMEM and incubated in the same buffer containing 32p; (20 , uCi/ml) for 1 hr at 370C. Cells were washed and treated with or without phorbol esters. The cells were then incubated in the absence or presence of 10 ,M norepinephrine (NE) at 37TC in a total volume of 0.9 ml (3 x 106 cells). In the first series of experiments (Fig. 1 ), cells were washed once with ice-cold buffer after treatment with phorbol esters and were further stimulated with 10 AM NE for 10 min. The same results were obtained when NE was coincubated with the phorbol esters. In the second series of experiments (Fig.  5) , in which the effects of short-time phorbol ester treatment were investigated, cells were stimulated with 10 AM NE for 1 min following phorbol ester treatment. At 1 min of NE stimulation, phosphatidic acid (PtdOH) 32p labeling was the most convenient parameter to follow. Phospholipid 32p labeling was stable up to 20 min after 32Pi removal. Incubation with NE was terminated with 2 ml of ice-cold methanol/HCl (100:1) and phospholipids were extracted according to Agranoff et al. (31) and measured according to Jolles et al. (32) . The migration of the labeled phospholipids was verified with authentic phospholipids visualized with iodine vapor. Following thin-layer chromatography and autoradiography, the bands were cut and the 32p was quantitated.
Membrane and Receptor Purification. Whole cells (109) were lysed by resuspension in hypotonic buffer (5 mM Tris HCl/10 mM NaF/5 mM EDTA, pH 7.4) and membranes were pelleted at 45,000 x g for 20 min. The pellet was resuspended in 10 ml of buffer (50 mM Tris HCl/10 mM NaF, pH 7.4) and sonicated by six 5-sec bursts with 1 min between the bursts at 4°C. The membrane suspension was'diluted to 40 ml and centrifuged at 600 x g for 10 min. This supernatant was centrifuged at 45,000 x g for 15 min. The pellet was washed twice in the same buffer. The membranes were then solubilized by sonication for 90 sec with 3.5 ml of 1% digitonin in 50 mM Tris'HCI/48% glycerol/150 mM NaCl/5 mM EDTA, pH 7.4, including leupeptin (10 ,tg/ml), soybean trypsin inhibitor (10 ,ug/ml), and bacitracin (200 ,ug/ml). The resulting suspension was diluted 1:2 with the above buffer lacking digitonin and glycerol and was centrifuged at 45,000 x g for 90 min. The supernatant was frozen in liquid N2 and stored at -70°C. The soluble extract (7 ml) was thawed and applied to 9 ml of Affi-Gel-A55414 (see below) preequilibrated with 3 column vol of 50 mM Tris HCI/150 mM NaCI/5 mM EDTA/10 mM NaF/0.05% digitonin/24% glycerol, pH 7.4, including the above protease inhibitors. After entering the resin, the soluble extract was allowed to equilibrate with the resin for 30 min at 25°C and then for 15 min at 4°C. The resin was then washed with 3 column vol of ice-cold equilibration buffer lacking glycerol but including 300 mM NaCl. After the temperature of the resin returned to 25°C ('15 min), the a1 receptor was eluted with 3 column vol of the same buffer but including 200 ,M phentolamine. The phentolamine eluate was then concentrated to -1 ml on an Amicon Centriflo ultrafiltration membrane'cone by centrifugation at 600 x g. The concentrate was then desalted on a Sephadex G-50 column (0.5 x 12 cm). An HEAT by Sephadex G-50 chromatography. Whole cell receptor binding assays were performed by incubating cells with 125I-HEAT with and without competitor in phosphatebuffered saline including 0.1% bovine serum albumin in a volume of 0.4 ml for 30 min at 370C. The assays were terminated with ice-cold buffer and were filtered on Whatman GF/C filters and filters washed with an additional 20 ml of buffer. Binding data were analyzed by nonlinear leastsquares computer curve fitting and the significance of differences between fitted parameters was tested as described (35) .
Photoaffinity Labeling. Photoaffinity labeling of purified plasma membranes was performed as described (36) . Purified a,-receptor preparations were photoaffinity labeled by incubation with 1 nM 4-amino-6,7-dimethoxy-2-{4- [5-(4-azido-3- [1251]iodophenyl)pentanoyl]-1-piperazinyl}quinazoline ([125I]APDQ) in a volume of 0.5 ml overnight at 40C. The mixture was desalted on Sephadex G-50 columns (0.5 x 12 cm) into 5 mM Tris HCl/0.05% digitonin, pH 6.8. The eluate was irradiated for 90 sec (36) . The photolyzed preparation was lyophilized and then dissolved in 0.1 ml of NaDodSO4/ PAGE sample buffer. NaDodSO4/PAGE. Gel electrophoresis was performed according to the method of Laemmli (37) with 10% slab gels. Gels were dried and autoradiographed at -80°C with Kodak XAR-5 films and intensifying screens. After autoradiographic visualization the gel was sliced and rehydrated and the 32P was quantitated by liquid scintillation spectroscopy.
Preparation of Affi-GeI-A55414. Affi-Gel 202 (a succinylaminoalkyl derivative of crosslinked Bio-Gel A) was incubated with A55414 by using a ratio of 120 g (1.86 mmol of succinylaminoalkyl groups) of wet gel cake to 240 mg (0.48 mmol) of A55414 in 120 ml of 50% dimethylformamide (DMF)/H20, pH 4.5, in the presence of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDAC) (2.4 mmol). The same amount of EDAC was added again after 5 min and after 70 min. After 18 hr of incubation at 22°C the gel was allowed to react for an additional 2 hr with glycine (2.4 mmol) and EDAC (2.4 mmol) to block any unreacted succinylaminoalkyl groups. The gel was then washed extensively with 1 liter of 50% DMF/H20, 2 liters of H20, 1 liter of 6 M guanidine HCl, 12 liters of H20, and 4 liters of 25 mM Tris HCl (pH 7.4).
ATP Determination. The specific activity of the labeled ATP was determined as described (38) Preincubation of cells with active phorbol esters for 10 min resulted in a drastic attenuation of the NE-promoted stimulation of PtdIns and PtdOH labeling. Fig. 1 shows that this attenuation occurred after preincubation with 0.1 ,M 4f-phorbol 12f3-myristate 13a-acetate (PMA) or with 1 ,M 4,-phorbol 12,B,13a-didecanoate (,3PDD). By contrast, the nontumor-promoting 4a-phorbol 12,B,13a-didecanoate (aPDD) had no effect.
Intact DDT1 MF-2 cells in suspension culture and at a density of -300,000 cells per ml contain 54,800 ± 2700 (mean ± SEM; n = 8) a1 receptors per cell, as determined by specific 1251-HEAT binding. Incubation of intact cells with tumor-promoting phorbol esters for 10 min resulted in no apparent change in the total number of a1 receptors per cell or antagonist affinity for the antagonist 125I-HEAT (Fig. 2 Upper). On the other hand, the potency of the agonist NE in competition for 125I-HEAT binding was reduced, as shown in Fig. 2 Lower (see Fig. 2 in Fig. 3 Inset, the major a1-receptor peptide labeled by
[1251]APDQ in the purified preparations was of Mr 80,000.
Fig . 4A shows the results when the a1 receptor was purified by affinity chromatography from 32P-labeled cells pretreated or not pretreated with active phorbol esters and such preparations were subjected to NaDodSO4/PAGE. In the absence of phorbol esters (control), purification yielded a phosphorylated peptide Of Mr 80,000. Exposure of cells to 100 nM PMA resulted in an increase in the 32p content of the M, 80,000 peptide. The active 8PDD, but not the inactive aPDD, at 500 nM also increased the 32p content of the same peptide. (40) . The choice between these two possibilities will require further experimentation. Protein kinase C-mediated phosphorylation of the receptor for transferrin appears to trigger its internalization, albeit perhaps for very different reasons (41) .
There is an obvious analogy in the actions of phorbol esters on a,-and f3-adrenergic receptors, although these receptors are coupled to different effector systems (PtdIns turnover versus adenylate cyclase). In each case the phosphorylated receptor appears to be functionally uncoupled from its biological effector system (27, 28 
